CAR T-Cell Therapy: New Hope for Remission in Leukemia
Gurpreet S. Lamba, MD What are the main types of leukemia? How do they differ in terms of their effects,
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Gurpreet S. Lamba, MD What are the main types of leukemia? How do they differ in terms of their effects,
Dr. Joel Silver How do myeloma and chronic lymphocytic leukemia (CLL) develop? What are some risk factors associated with those
As the third most common cancer in the United States, colorectal cancer (CRC) affects about 1 in 20 Americans. However,
Ralph V. Boccia, MD, a cancer specialist at RCCA Maryland, provides some insight into recent colorectal cancer trends and treatments
RCCA’s Annual Clinical Retreat is held, in concert with corporate partners, to allow Oncologists, Advanced Practice Nurses, Oncology Nurses and
To see the full corporate profile, please click here. https://www.youtube.com/embed/zMitJhH8D6g?ecver=1 Share on facebook Share on twitter Share on linkedin Share
HACKENSACK, N.J., January 17, 2017 – With more than 20 existing cancer care delivery locations throughout New Jersey, Maryland and
The need for viable and effective cancer treatment options has spurred the research and development of multiple strategies for helping
HACKENSACK, N.J., Nov. 22, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates (RCCA) is expanding its cancer care payment initiative with UnitedHealthcare
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.